10.3(top 1%)
Impact Factor
11(top 1%)
extended IF
24(top 15%)
H-Index
589
authors
310
papers
2.9K
citations
565
citing journals
2.6K
citing authors

Most Cited Articles of JHEP Reports

TitleYearCitations
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper2020280
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options2019116
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism2019100
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic202068
Limitations of non-invasive tests for assessment of liver fibrosis202054
Lifestyle modification in NAFLD/NASH: Facts and figures201948
Non-alcoholic fatty liver disease in lean individuals201947
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease201946
Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017201942
The role of the gut microbiome in chronic liver disease: the clinical evidence revised201941
Immunobiology of cholangiocarcinoma201937
Liver cancer: A leading cause of cancer death in the United States and the role of the 1945-1965 birth cohort by ethnicity201930
Beta-blockers in cirrhosis: Evidence-based indications and limitations202030
Anticoagulation in the cirrhotic patient201929
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg202027
Controversies in the management of hepatocellular carcinoma201926
NAFLD and liver transplantation: Disease burden, current management and future challenges202026
Radiotherapy for HCC: Ready for prime time?201925
Where does TIPS fit in the management of patients with cirrhosis?202025
Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment202125
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group201924
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors202023
knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice201922
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area202122
Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications201921